Characteristics of SARS-CoV-2 and potential pharmacological treatment

Authors

  • Leon Pawlik Zakład Biochemii, Katedra Chemii i Biochemii Medycznej, Uniwersytet Medyczny w Łodzi
  • Emilian Śpiołek Zakład Biochemii, Katedra Chemii i Biochemii Medycznej, Uniwersytet Medyczny w Łodzi
  • Jakub Fichna Zakład Biochemii, Katedra Chemii i Biochemii Medycznej, Uniwersytet Medyczny w Łodzi
  • Aleksandra Tarasiuk Zakład Biochemii, Katedra Chemii i Biochemii Medycznej, Uniwersytet Medyczny w Łodzi

DOI:

https://doi.org/10.18388/pb.2020_321

Abstract

In December 2019 in Wuhan, China the first cases of previously unknown, coronaviral infection-induced pneumonia have been reported. The new virus SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) was named after SARS-CoV due to their similarities and the disease caused by the pathogen is COVID-19 (Coronavirus Disease 2019). On 11 March 2020 WHO (World Health Organization) defined the rapidly increasing number of incidents of COVID-19 as a pandemic. In this review we will present recent information about the SARS-CoV-2 focusing on the origin, clinical picture, diagnostic methods, structure, replication cycle of SARS-CoV-2 and potential pharmaceutical measures against COVID-19.

Downloads

Download data is not yet available.

Published

2020-05-09

Issue

Section

Articles